PREVAIL THERAPEUTICS INC's ticker is PRVL and the CUSIP is 74140Y101. A total of 47 filers reported holding PREVAIL THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $248,000 | +210.0% | 10,768 | +36.6% | 0.00% | – |
| Q3 2020 | $80,000 | -25.2% | 7,882 | +9.6% | 0.00% | – |
| Q2 2020 | $107,000 | +75.4% | 7,194 | +42.7% | 0.00% | – |
| Q1 2020 | $61,000 | +52.5% | 5,043 | +95.8% | 0.00% | – |
| Q4 2019 | $40,000 | +60.0% | 2,575 | +25.1% | 0.00% | – |
| Q3 2019 | $25,000 | – | 2,059 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 13,822,463 | $140,713,000 | 1.77% |
| Omega Fund Management, LLC | 187,538 | $1,909,000 | 0.52% |
| Boxer Capital, LLC | 1,123,105 | $11,433,000 | 0.40% |
| RA Capital Management | 1,915,568 | $19,500,000 | 0.36% |
| DAFNA Capital Management LLC | 75,000 | $764,000 | 0.25% |
| QVT Financial LP | 133,690 | $1,361,000 | 0.17% |
| Woodline Partners LP | 385,480 | $3,924,000 | 0.13% |
| Virtus ETF Advisers LLC | 19,773 | $201,000 | 0.10% |
| WEXFORD CAPITAL LP | 37,963 | $386,000 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 53,018 | $540,000 | 0.09% |